表紙
市場調查報告書

基於細胞的分析和高內涵篩選市場:按應用預測(2021-2025)

Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2021 to 2025

出版商 Howe Sound Research 商品編碼 969252
出版日期 內容資訊 英文 250 Pages
商品交期: 最快1-2個工作天內
價格
基於細胞的分析和高內涵篩選市場:按應用預測(2021-2025) Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2021 to 2025
出版日期: 2020年11月05日內容資訊: 英文 250 Pages
簡介

基於細胞的測定在藥物開發和科學研究中起著主導作用,但是隨著對COVID-19治療的競爭加速,基於細胞的測定和高含量篩選市場正在迅速增長,並且該市場將繼續。預計增長。

本報告調查了全球基於細胞的測定和高內涵篩選市場,包括市場規模,增長和限制因素,技術發展,用戶類型/產品類別/區域市場分析,競爭狀況和關鍵因素。它提供諸如公司資料之類的信息。

目錄

市場指南

  • 情況分析和COVID-19的影響
  • 高管和營銷人員指南
  • 投資分析師和管理顧問指南

第1章市場介紹和定義

  • 什麼是基於細胞的測定?
  • 臨床試驗失敗
  • 市場定義
  • 調查方法
  • 美國醫療市場和藥物研究支出:前景

第2章基於細胞的分析技術指南

  • 細胞培養
  • 細胞測定
  • 細胞存活率測定
  • 細胞增殖測定
  • 細胞毒性測定
  • 細胞老化測定
  • 細胞凋亡
  • 自噬
  • 壞死
  • 氧化應激
  • 2D和3D
  • 信號通路,GPCR
  • 免疫調節和抑制
  • 記者基因工程
  • CBA設計與開發
  • 基於細胞的測定法

第3章行業概述

  • 市場進入公司
    • 學術研究室
    • 合同研究機構
    • 基因組儀器供應商
    • 細胞系和試劑供應商
    • 製藥公司
    • 審計機構
    • 認證機構

第4章市場趨勢

  • 生長因子
    • 候選人成長
    • 免疫腫瘤學
    • 基因組暴雪
    • 技術融合
    • 保險作用
  • 抑製器
    • CBA發展挑戰
    • 設備集成
    • 協議
  • 技術發展
    • 3D分析
    • 自動化
    • 軟件
    • 一次電池
    • 信號傳導和報告基因
    • 未來5年

第5章基於細胞的分析的最新進展

  • 最新動態:本節的重要性和用法
    • 這些發展的重要性
    • 如何使用本節
      • Axxam和FUJIFILM Cellular Dynamics宣佈建立戰略聯盟
      • CuriBio收購了一家人工智能公司Dana Solutions
      • CRISPR篩選揭示了新的癌症治療靶標
      • ERS □□Genomics向Axxam授予CRISPR-Cas9專利
      • 新的轉錄本混合測定法可促進化合物篩選
      • 確定高通量抗癌候選藥物
      • 查爾斯河實驗室收購Citoxlab
      • 反應生物學公司收購ProQinase GmbH等。

第6章主要公司簡介

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

第7章全球市場規模

  • 全球市場概況(按國家)
  • 按用戶概述的全球市場
  • 全球產品類別概述

第8章按用戶類型劃分的全球市場

  • 製藥
  • 調查
  • 工業/化妝品

第9章按產品類別進行基於細胞的分析

  • 設備
  • 試劑
  • 服務
  • 軟件

第10章附錄

  • 年度FDA癌症藥物批准
  • 從2010年到2016年開始臨床試驗
  • 國家藥品研發份額
目錄

Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as the race for a COVID-19 cure gains speed. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research Seminar - Burke Institute

Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis & COVID-19 Impact
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What are Cell Based Assays?
  • 1.2 Clinical Trial Failures
    • 1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
    • 1.2.2 Infectious Disease Will Play a Larger Role
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and Pharmceutical Research Spending - Perspective
    • 1.5.1 U.S. Expenditures for Pharmaceutical Research

2. Cell Based Assays - Guide to Technology

  • 2.1 Cell Cultures
    • 2.1.1 Cell Lines
    • 2.1.2 Primary Cells
    • 2.1.3 Stem Cells
      • 2.1.3.1 iPSC's - The Special Case
  • 2.2 Cell Assays
  • 2.3 Cell Viability Assays
  • 2.3 Cell Proliferation Assays
  • 2.4 Cytotoxicity Assays
  • 2.5 Cell Senescence Assays
  • 2.6 Apoptosis
  • 2.7 Autophagy
  • 2.8 Necrosis
  • 2.9 Oxidative Stress
  • 2.10 2D vs. 3D
  • 2.11 Signalling Pathways, GPCR
  • 2.12 Immune Regulation & Inhibition
  • 2.13 Reporter Gene Technology
  • 2.14 CBA Design & Development
  • 2.15 Cell Based Assays - The Takeaway

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Contract Research Organization
    • 3.1.3 Genomic Instrumentation Supplier
    • 3.1.5 Cell Line and Reagent Supplier
    • 3.1.6 Pharmaceutical Company
    • 3.1.7 Audit Body
    • 3.1.8 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Candidate Growth
    • 4.1.2 Immuno-oncology
    • 4.1.3 Genomic Blizzard
    • 4.1.4 Technology Convergence
    • 4.1.5 The Insurance Effect
  • 4.2 Factors Limiting Growth
    • 4.2.1 CBA Development Challenges
    • 4.2.2 Instrument Integration
    • 4.2.3 Protocols
  • 4.3 Technology Development
    • 4.3.1 3D Assays
    • 4.3.2 Automation
    • 4.3.3 Software
    • 4.3.4 Primary Cells
    • 4.3.5 Signalling and Reporter Genes
    • 4.3.6 The Next Five Years

5. Cell Based Assays Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
      • Cancer Genetics to Acquire Organoid Startup Stemonix
      • Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
      • CRISPR Screens Uncover Novel Cancer Therapy Targets
      • ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam
      • New Transcriptomics Assay Facilitates Compound Screens
      • Carta Biosciences Betting on Gene Interaction Mapping
      • High-throughput Identifies cancer drug candidates
      • Velabs Therapeutics partners with Alytas Therapeutics to develop a novel immune-based therapy for obesity
      • InSphero platform selected to test Cyclerion's sGC stimulator technology
      • OcellO to provide in vitro research services to Merus
      • Charles River Laboratories to acquire Citoxlab
      • Reaction Biology Corporation Purchases ProQinase GmbH
      • Cisbio extends its assay portfolio for immuno-oncology drug discovery
      • STEMCELL Technologies Launches Next-Generation Culture System
      • Abcam Acquires Calico Biolabs
      • Evotec announces achievement in Celgene alliance utilizing IPSC screening
      • Fujifilm Cellular Dynamics Inc. launches iCELL Microglia
      • Cisbio and Excellerate Bioscience partner
      • Horizon Discovery extends CRISPR Screening Service to primary human T cells

6. Profiles of Key Cell Based Assay Companies

  • Abcam
  • Agilent
  • Aurora Instruments Ltd.
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments
  • BioVision, Inc.
  • BMG Labtech
  • Cell Biolabs, Inc
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories
  • Cisbio Bioassays
  • Corning, Inc.
  • Cytovale
  • Enzo Life Sciences, Inc.
  • Eurofins DiscoverX Corporation
  • Evotec AG
  • Excellerate Bioscience
  • Fujifilm Cellular Dynamics International
  • Genedata
  • Hemogenix
  • Horizon Discovery
  • Invivogen
  • Leica Biosystems
  • Lonza Group Ltd.
  • Luminex Corp
  • Merck & Co., Inc
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • Ncardia
  • New England Biolabs, Inc.
  • Olympus
  • Origene Technologies
  • Perkin Elmer
  • Promega
  • Qiagen Gmbh
  • Reaction Biology
  • Recursion Pharma
  • Roche Diagnostics
  • Sartorius
  • Sartorius-ForteBio
  • Sartorius-IntelliCyt
  • Sony Biotechnology
  • SPT Labtech
  • Stemcells Technologies Canada Inc.
  • Tecan
  • Thermo Fisher Scientific Inc.
  • Vitro Biopharma

7. Global Market Size

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market by User - Overview
    • 7.2.1 Table - Global Market by User
    • 7.2.2 Chart - Global Market by User - Base/End Year Comparison
    • 7.2.3 Chart - Global Market by User - Base Year
    • 7.2.4 Chart - Global Market by User - End Year
    • 7.2.5 Chart - Global Market by User - Share by Year
  • 7.3 Global Market by Product Class - Overview
    • 7.3.1 Table - Global Market by Product Class
    • 7.3.2 Chart - Global Market by Product Class - Base/End Year Comparison
    • 7.3.3 Chart - Global Market by Product Class - Base Year
    • 7.3.4 Chart - Global Market by Product Class - End Year
    • 7.3.5 Chart - Global Market by Product Class - Share by Year

8. Global Market by User Type

  • 8.1 Pharma
    • 8.1.1 Table Pharma - by Country
    • 8.1.2 Chart - Pharma Growth
  • 8.2 Research
    • 8.2.1 Table Research - by Country
    • 8.2.2 Chart - Research Growth
  • 8.3 Industry/Cosmetic
    • 8.3.1 Table Industry/Cosmetic - by Country
    • 8.3.2 Chart - Industry/Cosmetic Growth

9. Cell Based Assay by Product Class

  • 9.1 Instrument
    • 9.1.1 Table Instrument - by Country
    • 9.1.2 Chart - Instrument Growth
  • 9.2 Reagent
    • 9.2.1 Table Reagent - by Country
    • 9.2.2 Chart - Reagent Growth
  • 9.3 Services
    • 9.3.1 Table Services - by Country
    • 9.3.2 Chart - Services Growth
  • 9.4 Software
    • 9.4.1 Table Software - by Country
    • 9.4.2 Chart - Software Growth

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Share of Pharma R&D by Country

Table of Tables

  • Table 1 The Large Variety of Cell Lines
  • Table 2 Some Common Viability Assays
  • Table 3 Oxidative Stress Related Diseases
  • Table 4 Important Signalling Pathways
  • Table 5 Market Players by Type
  • Table 6 Five Factors Driving Growth
  • Table 7 Three Factors Limiting Growth
  • Table 8 - Global Market by Region
  • Table 9 Global Market by User
  • Table 10 Global Market by Product Class
  • Table 11 Pharma by Country
  • Table 12 Research by Country
  • Table 13 Industry/Cosmetic by Country
  • Table 14 Instrument by Country
  • Table 15 Reagent by Country
  • Table 16 Services by Country
  • Table 17 Software by Country

Table of Figures

  • Figure 1 Reasons for clinical Failure by Phase
  • Figure 2 Immunotherapy Clinical Trial Growth
  • Figure 3 Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
  • Figure 4 Oxidative Stress and Free Radical Toxicity
  • Figure 5 FDA Cancer Drug Approvals
  • Figure 6 Growth rates of Cell Based Assays by Product Class
  • Figure 7 Global Market Share Chart
  • Figure 8 Global Market by User - Base vs. End Year
  • Figure 9 Global Market by User Base Year
  • Figure 10 Global Market by User End Year
  • Figure 11 User Share by Year
  • Figure 12 Global Market by Product Class - Base vs. End Year
  • Figure 13 Global Market by Product Class Base Year
  • Figure 14 Global Market by Product Class End Year
  • Figure 15 Product Class Share by Year
  • Figure 16 Pharma Growth
  • Figure 17 Research Growth
  • Figure 18 Industry/Cosmetic Growth
  • Figure 19 Instrument Growth
  • Figure 20 Reagent Growth
  • Figure 21 Services Growth
  • Figure 22 Software Growth
  • Figure 23 FDA Cancer Drug Approvals by Year
  • Figure 24 Clinical Trials for Immunotherapy by Year
  • Figure 25 Share of Pharma R&D by Country